Joel Beatty
Stock Analyst at Baird
(4.63)
# 209
Out of 5,147 analysts
209
Total ratings
53.33%
Success rate
35.33%
Average return
Main Sectors:
Stocks Rated by Joel Beatty
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRAX Praxis Precision Medicines | Maintains: Outperform | $275 → $433 | $336.75 | +28.58% | 3 | Feb 20, 2026 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Outperform | $72 → $47 | $23.39 | +100.94% | 5 | Dec 30, 2025 | |
| CTNM Contineum Therapeutics | Maintains: Outperform | $16 → $14 | $15.34 | -8.74% | 3 | Nov 24, 2025 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Outperform | $160 → $209 | $190.02 | +9.99% | 5 | Nov 18, 2025 | |
| ELF e.l.f. Beauty | Maintains: Outperform | $145 → $125 | $92.05 | +35.80% | 9 | Nov 6, 2025 | |
| AMLX Amylyx Pharmaceuticals | Maintains: Outperform | $10 → $19 | $15.17 | +25.25% | 5 | Oct 16, 2025 | |
| LRMR Larimar Therapeutics | Maintains: Outperform | $10 → $7 | $5.31 | +31.83% | 3 | Sep 30, 2025 | |
| DNTH Dianthus Therapeutics | Maintains: Outperform | $50 → $67 | $55.19 | +21.40% | 3 | Sep 9, 2025 | |
| EDIT Editas Medicine | Maintains: Outperform | $4 → $6 | $2.20 | +172.73% | 5 | Aug 13, 2025 | |
| COGT Cogent Biosciences | Maintains: Neutral | $7 → $9 | $38.85 | -76.83% | 6 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $28 → $31 | $24.56 | +26.22% | 4 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $38 → $24 | $23.49 | +2.17% | 5 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $680 | $766.92 | -11.33% | 7 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $30 → $29 | $21.18 | +36.92% | 2 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $66 | $68.19 | -3.21% | 15 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $160 → $162 | $163.89 | -1.15% | 5 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $38 → $41 | $30.10 | +36.21% | 3 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $28 → $32 | $23.08 | +38.65% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $75 | $83.82 | -10.52% | 1 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $6 → $7 | $2.80 | +150.00% | 5 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $72 → $65 | $61.73 | +5.30% | 5 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $540 → $240 | $0.79 | +30,101.98% | 3 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $4.5 | $1.68 | +167.86% | 2 | Apr 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $24 → $25 | $15.97 | +56.54% | 3 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $32 → $28 | $21.71 | +28.97% | 2 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $16 | $1.29 | +1,140.31% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $4 → $1.25 | $1.35 | -7.41% | 2 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $44 | $1.30 | +3,284.62% | 3 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $60 → $58 | $63.27 | -8.33% | 6 | Feb 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $18 → $24 | $32.20 | -25.47% | 2 | Nov 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $18 | $8.23 | +118.71% | 3 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $9 → $6 | $1.94 | +209.28% | 2 | Aug 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $36 → $28 | $9.09 | +208.03% | 2 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $170 → $175 | $332.92 | -47.43% | 2 | Feb 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $14 | $8.91 | +57.13% | 8 | Jan 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $108 | $16.76 | +544.39% | 10 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $78 | $81.15 | -3.88% | 3 | Aug 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $140 → $100 | $20.99 | +376.42% | 2 | Apr 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $480 → $120 | $13.80 | +769.57% | 14 | Apr 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $480 → $450 | $3.44 | +12,981.40% | 2 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $3.35 | - | 12 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $15 | $10.14 | +47.93% | 11 | Sep 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $14 → $11 | $12.35 | -14.98% | 8 | Aug 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $2,400 → $1,200 | $0.19 | +648,548.65% | 2 | Aug 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $19 | $8.73 | +117.64% | 3 | Nov 10, 2017 |
Praxis Precision Medicines
Feb 20, 2026
Maintains: Outperform
Price Target: $275 → $433
Current: $336.75
Upside: +28.58%
Ultragenyx Pharmaceutical
Dec 30, 2025
Maintains: Outperform
Price Target: $72 → $47
Current: $23.39
Upside: +100.94%
Contineum Therapeutics
Nov 24, 2025
Maintains: Outperform
Price Target: $16 → $14
Current: $15.34
Upside: -8.74%
Jazz Pharmaceuticals
Nov 18, 2025
Maintains: Outperform
Price Target: $160 → $209
Current: $190.02
Upside: +9.99%
e.l.f. Beauty
Nov 6, 2025
Maintains: Outperform
Price Target: $145 → $125
Current: $92.05
Upside: +35.80%
Amylyx Pharmaceuticals
Oct 16, 2025
Maintains: Outperform
Price Target: $10 → $19
Current: $15.17
Upside: +25.25%
Larimar Therapeutics
Sep 30, 2025
Maintains: Outperform
Price Target: $10 → $7
Current: $5.31
Upside: +31.83%
Dianthus Therapeutics
Sep 9, 2025
Maintains: Outperform
Price Target: $50 → $67
Current: $55.19
Upside: +21.40%
Editas Medicine
Aug 13, 2025
Maintains: Outperform
Price Target: $4 → $6
Current: $2.20
Upside: +172.73%
Cogent Biosciences
Jul 8, 2025
Maintains: Neutral
Price Target: $7 → $9
Current: $38.85
Upside: -76.83%
May 19, 2025
Maintains: Outperform
Price Target: $28 → $31
Current: $24.56
Upside: +26.22%
May 16, 2025
Downgrades: Neutral
Price Target: $38 → $24
Current: $23.49
Upside: +2.17%
May 13, 2025
Upgrades: Outperform
Price Target: $680
Current: $766.92
Upside: -11.33%
May 8, 2025
Maintains: Outperform
Price Target: $30 → $29
Current: $21.18
Upside: +36.92%
May 7, 2025
Maintains: Outperform
Price Target: $70 → $66
Current: $68.19
Upside: -3.21%
May 6, 2025
Maintains: Outperform
Price Target: $160 → $162
Current: $163.89
Upside: -1.15%
May 2, 2025
Maintains: Outperform
Price Target: $38 → $41
Current: $30.10
Upside: +36.21%
Mar 3, 2025
Maintains: Outperform
Price Target: $28 → $32
Current: $23.08
Upside: +38.65%
Nov 25, 2024
Initiates: Outperform
Price Target: $75
Current: $83.82
Upside: -10.52%
Nov 15, 2024
Maintains: Outperform
Price Target: $6 → $7
Current: $2.80
Upside: +150.00%
Oct 30, 2024
Maintains: Neutral
Price Target: $72 → $65
Current: $61.73
Upside: +5.30%
May 15, 2024
Maintains: Outperform
Price Target: $540 → $240
Current: $0.79
Upside: +30,101.98%
Apr 30, 2024
Downgrades: Neutral
Price Target: $4.5
Current: $1.68
Upside: +167.86%
Apr 11, 2024
Maintains: Outperform
Price Target: $24 → $25
Current: $15.97
Upside: +56.54%
Oct 3, 2023
Maintains: Outperform
Price Target: $32 → $28
Current: $21.71
Upside: +28.97%
Jun 1, 2023
Initiates: Outperform
Price Target: $16
Current: $1.29
Upside: +1,140.31%
May 2, 2023
Maintains: Outperform
Price Target: $4 → $1.25
Current: $1.35
Upside: -7.41%
Apr 13, 2023
Initiates: Outperform
Price Target: $44
Current: $1.30
Upside: +3,284.62%
Feb 7, 2023
Maintains: Outperform
Price Target: $60 → $58
Current: $63.27
Upside: -8.33%
Nov 18, 2022
Maintains: Outperform
Price Target: $18 → $24
Current: $32.20
Upside: -25.47%
Nov 10, 2022
Downgrades: Underperform
Price Target: $18
Current: $8.23
Upside: +118.71%
Aug 29, 2022
Maintains: Outperform
Price Target: $9 → $6
Current: $1.94
Upside: +209.28%
Mar 3, 2022
Upgrades: Neutral
Price Target: $36 → $28
Current: $9.09
Upside: +208.03%
Feb 12, 2021
Downgrades: Neutral
Price Target: $170 → $175
Current: $332.92
Upside: -47.43%
Jan 14, 2021
Downgrades: Neutral
Price Target: $14
Current: $8.91
Upside: +57.13%
Jan 12, 2021
Downgrades: Neutral
Price Target: $108
Current: $16.76
Upside: +544.39%
Aug 10, 2020
Maintains: Buy
Price Target: $80 → $78
Current: $81.15
Upside: -3.88%
Apr 6, 2020
Maintains: Buy
Price Target: $140 → $100
Current: $20.99
Upside: +376.42%
Apr 1, 2020
Maintains: Buy
Price Target: $480 → $120
Current: $13.80
Upside: +769.57%
Mar 26, 2020
Maintains: Buy
Price Target: $480 → $450
Current: $3.44
Upside: +12,981.40%
Mar 17, 2020
Upgrades: Buy
Price Target: n/a
Current: $3.35
Upside: -
Sep 24, 2019
Maintains: Buy
Price Target: $19 → $15
Current: $10.14
Upside: +47.93%
Aug 17, 2018
Upgrades: Neutral
Price Target: $14 → $11
Current: $12.35
Upside: -14.98%
Aug 17, 2018
Maintains: Neutral
Price Target: $2,400 → $1,200
Current: $0.19
Upside: +648,548.65%
Nov 10, 2017
Maintains: Buy
Price Target: $15 → $19
Current: $8.73
Upside: +117.64%